Results 151 to 160 of about 280,326 (218)

Single-cell multiomic analysis unveils the immune landscape dynamics of graves' ophthalmopathy. [PDF]

Commun Biol
Ke S, Liu Z, Zhou M, Xiao B, Hu Q, Lin J, Ye H, Luo L, Lin X.   +8 more
europepmc   +1 more source

A Case of Euthyroid Graves' Ophthalmopathy With Negative Thyroid Antibodies. [PDF]

Cureus
Abu Helwa RS, Subeh HH, Katreddy V, Ahmed AI.   +3 more
europepmc   +1 more source

Molecular biomarkers of Graves' ophthalmopathy.

Experimental and molecular pathology (Print), 2019
C. M. Longo, P. Higgins
semanticscholar   +1 more source

Orbital Radiotherapy for Graves' Ophthalmopathy: Single Institutional Experience of Efficacy and Safety. [PDF]

Diseases
La Rocca M, Leonardi BF, Lo Greco MC, Marano G, Milazzotto R, Liardo RLE, Acquaviva G, La Monaca VA, Salamone V, Basile A, Foti PV, Palmucci S, David E, Parisi S, Pontoriero A, Pergolizzi S, Spatola C.   +16 more
europepmc   +1 more source

"Real-Life" Utility of the Graves' Ophthalmopathy-Quality of Life in a Multidisciplinary Thyroid Eye Disease Service. [PDF]

Ophthalmic Plast Reconstr Surg
Virdee S, Moledina M, Lee V.
europepmc   +1 more source

Hypoxia-Dependent HIF-1 Activation Impacts on Tissue Remodeling in Graves' Ophthalmopathy-Implications for Smoking.

Journal of Clinical Endocrinology and Metabolism, 2016
Gina-Eva Görtz, M. Horstmann, Barbara Aniol, B. D. Reyes, J. Fandrey, A. Eckstein, U. Berchner‐Pfannschmidt   +6 more
semanticscholar   +1 more source

Medial wall orbital decompression surgery for the treatment of Graves' ophthalmopathy: follow-up results in a single medical center. [PDF]

Int Ophthalmol
Ben Ishai M, Yagoda D, Dadon J, Shochat T, Soudry E, Avisar I.   +5 more
europepmc   +1 more source

A Preclinical State of Graves' Ophthalmopathy Characterized by Hypoxia of T-cells Identified via Multiomics Analysis.

J Clin Endocrinol Metab
Zhang M, Qi X, Zhou X, Liu Y, He M, Wang J, Wang L, Chen Z, Li S, Chen Y, Sun Y, Guo H, Yang J, Shi B, Wang Y.   +14 more
europepmc   +1 more source

Genetic and Plasma Proteomic Approaches to Identify Therapeutic Targets for Graves' Disease and Graves' Ophthalmopathy. [PDF]

Immunotargets Ther
Ke C, Yu Y, Li J, Yu Y, Sun Y, Wang Y, Wang B, Lu Y, Tang M, Wang N, Chen Y.   +10 more
europepmc   +1 more source

Acute liver damage following intravenous glucocorticoid treatment for Graves’ ophthalmopathy

Endocrine, 2016
M. Moleti, G. Giuffrida, G. Sturniolo, G. Squadrito, A. Campenní, Silvia Morelli, E. Puxeddu, E. Sisti, F. Trimarchi, F. Vermiglio, M. Marinò   +10 more
semanticscholar   +1 more source